Gene Therapy. Redefined.
We are a biopharmaceutical company developing life-changing gene therapies for conditions affecting millions of people around the world. Our mission is to make gene therapies accessible – not just for the few – but for the many.
Therapeutic Program Areas
Kriya is targeting diseases that impact millions of people worldwide and represent areas of high unmet need. We target validated biological pathways with innovative gene therapy approaches that have the potential to deliver transformative benefits.
In the News
Our Investors
We are backed by leading healthcare and technology investors who are committed to our goal of building the world’s leading gene therapy biopharmaceutical company. Since our founding in 2019, Kriya has raised over $900 million in investments.
